Arsenic trioxide entered cerebrospinal fluid with the help of mannitol overwhelm the meningeal relapse of acute promyelocytic leukemia.
Jin
Z
Z
The First Hospital of Harbin Medical University, Harbin, China.
Ran
M
M
Man
Z
Z
D000328:Adult; D000970:Antineoplastic Agents / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D017209:Apoptosis; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D015473:Leukemia, Promyelocytic, Acute / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008353:Mannitol / Q000378:metabolism*; D008577:Meningeal Neoplasms / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D010087:Oxides / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D012074:Remission Induction
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D008353:Mannitol; D000077237:Arsenic Trioxide